Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc.DNA · Entity 5530 | See remarks | May 20, 2025 | May 22, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ginkgo Bioworks Holdings, Inc.
Report date May 20, 2025 · Filed May 22, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 46,226 |
Ending reported balance
After 2025-05-21 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-05-20 · Exercise / conversion · Acquired 454 · Balance 45,907 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Row 2 · 2025-05-20 · Exercise / conversion · Acquired 453 · Balance 46,360 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Row 3 · 2025-05-20 · Exercise / conversion · Acquired 572 · Balance 46,932 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Row 4 · 2025-05-21 · Sale · Disposed 706 · Balance 46,226 F2: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,614 |
Reported balance
After 2025-05-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-05-20 · Exercise / conversion · Disposed 454 · Balance 3,614 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,970 |
Reported balance
After 2025-05-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-05-20 · Exercise / conversion · Disposed 453 · Balance 9,970 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,488 |
Reported balance
After 2025-05-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-05-20 · Exercise / conversion · Disposed 572 · Balance 19,488 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
F3: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023.
F4: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2023 Filed Dec 6, 2023 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,281 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-029012 · form4.xml · derivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 974,067 Underlying: Class A Common Stock · 65,281 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| December 01, 2023 Filed Dec 6, 2023 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-029012 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 719,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| December 01, 2023 Filed Dec 6, 2023 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-029012 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 717,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| December 01, 2023 Filed Dec 6, 2023 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,281 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-029012 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 699,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 17:21 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,229 | $1.50 | $55,917.96 |
DisclosureSEC source: 0001127602-23-026863 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 634,206 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 01, 2023 Filed Nov 6, 2023 17:21 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,635 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-026863 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 636,865 Underlying: Class A Common Stock · 1,635 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F6 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| November 01, 2023 Filed Nov 6, 2023 17:21 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-026863 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 725,000 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| November 01, 2023 Filed Nov 6, 2023 17:21 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-026863 · form4.xml · derivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,039,348 Underlying: Class A Common Stock · 65,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| November 01, 2023 Filed Nov 6, 2023 17:21 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,635 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-026863 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 671,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| November 01, 2023 Filed Nov 6, 2023 17:21 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-026863 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 669,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| November 01, 2023 Filed Nov 6, 2023 17:21 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-026863 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 651,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:18 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 42,237 | $1.76 | $74,463.83 |
DisclosureSEC source: 0001127602-23-025518 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 586,393 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 01, 2023 Filed Oct 4, 2023 17:18 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,637 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-025518 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638,500 Underlying: Class A Common Stock · 1,637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F6 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| October 01, 2023 Filed Oct 4, 2023 17:18 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-025518 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 743,125 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| October 01, 2023 Filed Oct 4, 2023 17:18 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-025518 · form4.xml · derivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,104,630 Underlying: Class A Common Stock · 65,283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| October 01, 2023 Filed Oct 4, 2023 17:18 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,637 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-025518 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 628,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| October 01, 2023 Filed Oct 4, 2023 17:18 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-025518 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 626,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| October 01, 2023 Filed Oct 4, 2023 17:18 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-025518 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 608,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 41,417 | $2.24 | $92,567.00 |
DisclosureSEC source: 0001127602-23-023812 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 543,585 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,636 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-023812 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 640,137 Underlying: Class A Common Stock · 1,636 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F6 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-023812 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 761,250 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-023812 · form4.xml · derivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,169,913 Underlying: Class A Common Stock · 65,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,636 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-023812 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 585,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-023812 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 583,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-023812 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 565,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 17:10 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 46,519 | $2.07 | $96,247.81 |
DisclosureSEC source: 0001127602-23-022033 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 499,959 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| August 01, 2023 Filed Aug 4, 2023 17:10 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,638 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-022033 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 641,773 Underlying: Class A Common Stock · 1,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F6 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| August 01, 2023 Filed Aug 4, 2023 17:10 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-022033 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 779,375 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| August 01, 2023 Filed Aug 4, 2023 17:10 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-022033 · form4.xml · derivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,235,195 Underlying: Class A Common Stock · 65,283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| August 01, 2023 Filed Aug 4, 2023 17:10 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,638 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-022033 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 546,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| August 01, 2023 Filed Aug 4, 2023 17:10 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-022033 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 544,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| August 01, 2023 Filed Aug 4, 2023 17:10 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-022033 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 17:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 40,637 | $1.80 | $73,227.87 |
DisclosureSEC source: 0001127602-23-020422 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 461,432 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| July 01, 2023 Filed Jul 6, 2023 17:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020422 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 643,411 Underlying: Class A Common Stock · 1,634 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F6 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| July 01, 2023 Filed Jul 6, 2023 17:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020422 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 797,500 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| July 01, 2023 Filed Jul 6, 2023 17:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020422 · form4.xml · derivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,300,478 Underlying: Class A Common Stock · 65,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| July 01, 2023 Filed Jul 6, 2023 17:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020422 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 502,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| July 01, 2023 Filed Jul 6, 2023 17:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020422 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| July 01, 2023 Filed Jul 6, 2023 17:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020422 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 482,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 40,511 | $1.57 | $63,399.72 |
DisclosureSEC source: 0001127602-23-018066 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 417,028 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| June 01, 2023 Filed Jun 6, 2023 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,635 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-018066 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 645,045 Underlying: Class A Common Stock · 1,635 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F6 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| June 01, 2023 Filed Jun 6, 2023 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-018066 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 815,625 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| June 01, 2023 Filed Jun 6, 2023 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,284 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-018066 · form4.xml · derivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,365,760 Underlying: Class A Common Stock · 65,284 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| June 01, 2023 Filed Jun 6, 2023 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,635 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-018066 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 457,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| June 01, 2023 Filed Jun 6, 2023 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-018066 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 455,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| June 01, 2023 Filed Jun 6, 2023 17:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,284 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-018066 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 437,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| May 22, 2023 Filed May 24, 2023 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 250,000 | $1.50 | $375,000.00 |
DisclosureSEC source: 0001127602-23-016746 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 372,495 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| May 02, 2023 Filed May 4, 2023 20:16 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 38,802 | $1.15 | $44,505.89 |
DisclosureSEC source: 0001127602-23-014598 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 622,495 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| May 01, 2023 Filed May 4, 2023 20:16 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,637 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-014598 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 646,680 Underlying: Class A Common Stock · 1,637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F6 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| May 01, 2023 Filed May 4, 2023 20:16 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-014598 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 833,750 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.